Skip to main content

Table 1 Requirements for the study

From: Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial

  1. 1every 3 months;
  2. 2if no imaging has been performed within the last 4 weeks.
  3. 3to be performed at the beginning of each cycle.
  4. 4to be followed beyond the 30 days until resolution or stabilization
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us